Fund Name | : | SBI Mutual Fund |
Scheme Name | : | SBI Healthcare Opportunities Fund (G) |
AMC | : | SBI Mutual Fund |
Type | : | O |
Category | : | Equity - Pharma |
Launch Date | : | 04-Jun-1999 |
Fund Manager | : | Tanmaya Desai |
Net Assets (Rs. cr) | : | 2608.3 |
Invest wise with Expert advice
Get better recommendations Make better investments.
Get better recommendations Make better investments.
By continuing, I accept the Terms & Conditions and agree to receive communication on Whatsapp
No Record Found
1w | 1m | 3m | 6m | 1y | 3y | 5y | Since INC | |
---|---|---|---|---|---|---|---|---|
Scheme Returns | -1.82 | -4.27 | 10.43 | 17.72 | 54.05 | 21.36 | 22.86 | 15.12 |
Category Avg | -2.76 | -2.84 | 11.01 | 18.64 | 56.29 | 18.67 | 23.20 | 17.87 |
Category Best | -1.96 | -1.10 | 14.25 | 23.95 | 63.75 | 20.83 | 27.36 | 28.70 |
Category Worst | -1.82 | -4.27 | 10.43 | 17.72 | 54.05 | 21.36 | 22.86 | 15.12 |
Dividends | Bonus |
---|
No Record Found
Min. Investment(Rs.) | : | 5000 |
Increm.Investment(Rs.) | : | 1000 |
Calculate the worth of your wealth at retirement
In | |
Name of the Company | No of shares |
No Record Found
Out | |
Name of the Company | No of shares |
No Record Found
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) | ||||
---|---|---|---|---|---|---|---|---|---|
Equity & Equity related Investments | |||||||||
Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 15.12 | 25,00,000.00 | 394.49 | ||||
Equity | Cipla | Pharmaceuticals & Biotechnology | 7.95 | 14,00,000.00 | 207.25 | ||||
Equity | Max Healthcare | Healthcare Services | 6.08 | 20,00,000.00 | 158.67 | ||||
Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 4.91 | 6,00,000.00 | 128.14 | ||||
Equity | Aether Industri. | Chemicals & Petrochemicals | 4.71 | 14,00,000.00 | 122.92 | ||||
Equity | Jupiter Life Lin | Healthcare Services | 4.49 | 8,49,810.00 | 117.10 | ||||
Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 4.41 | 3,30,000.00 | 115.13 | ||||
Equity | Global Health | Healthcare Services | 4.39 | 8,40,000.00 | 114.59 | ||||
Equity | Krishna Institu. | Healthcare Services | 4.33 | 5,00,000.00 | 112.86 | ||||
Foreign Equity | Lonza Group | Pharmaceuticals & Biotechnology | 4.16 | 2,50,000.00 | 108.40 | ||||
Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 4.06 | 6,00,000.00 | 105.96 | ||||
Equity | Rainbow Child. | Healthcare Services | 4.01 | 7,70,000.00 | 104.50 | ||||
Equity | Lupin | Pharmaceuticals & Biotechnology | 3.98 | 6,40,000.00 | 103.75 | ||||
Equity | Abbott India | Pharmaceuticals & Biotechnology | 3.49 | 32,000.00 | 90.99 | ||||
Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 3.31 | 8,40,000.00 | 86.36 | ||||
Equity | Fortis Health. | Healthcare Services | 3.13 | 20,00,000.00 | 81.60 | ||||
Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 3.07 | 3,00,000.00 | 79.98 | ||||
Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 2.95 | 1,50,000.00 | 76.91 | ||||
Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 2.53 | 7,00,000.00 | 65.93 | ||||
Equity | J B Chem & Pharm | Pharmaceuticals & Biotechnology | 2.40 | 4,00,000.00 | 62.47 | ||||
Equity | Laurus Labs | Pharmaceuticals & Biotechnology | 1.40 | 9,00,000.00 | 36.54 | ||||
Equity | Gufic BioScience | Pharmaceuticals & Biotechnology | 1.21 | 10,00,000.00 | 31.50 | ||||
Debt Investments | |||||||||
Corporate Debts | Shreno Ltd | -/- | 0.27 | 40,00,000.00 | 6.97 | ||||
Cash & Cash Equivalent | |||||||||
Reverse Repo | TREPS | -/- | 3.80 | 0.00 | 99.16 | ||||
Net CA & Others | Net CA & Others | -/- | -0.16 | 0.00 | -3.90 |
Fund House | : SBI Funds Management Ltd |
Incorporation Date | : 07-Feb-1992 |
Total Assets Managed (Cr.) | : 8,52,086.72 |
Trustee/s | : SBI Mutual Fund Trustee C |
Chairman | : N/A |
CEO / MD | : Mr. Shamsher Singh |
CIO | : N/A |
President | : N/A |
Director/s | : Om Prakash Gahrotra |
Compliance Officer/s | : N/A |
Investor Service Officer/s | : N/A |
Fund Manager/s | : Tanmaya Desai |
Auditors | : N/A |
Registered Office | : 9th Floor,Crescenzo, C-39&39, G Block, Bandra kurla complex, Bandra (east), Mumbai-400 051. |
Contact Nos | : 022-61793000 |
Fax | : 022-67425687 |
: partnerforlife@sbimf.com | |
Website | : www.sbimf.com |
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Copyright © IIFL Securities Ltd. All rights Reserved.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Copyright © IIFL Securities Ltd. All rights Reserved.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.